Transplantation Therapeutics Research: Talks about leading products and key unmet needs within the market

This leads to an anti-graft immune response that involves T cells invading the new tissue, multiplying, and recruiting more immune cells to the transplant site in order to remove this foreign body.

Pune, India - March 14, 2018 /MarketersMedia/ —

In 2015 a total of 127,000 transplantations were performed worldwide, an increase of 5.8% from 2014, with 33,000 of these occurring in the EU and 32,000 in the US. Approximately 60% of these were kidney transplants, with liver, heart, lung, pancreas and small bowel transplantations accounting for the other most common procedures (Dominguez-Gil and Matesanz, 2017). When a graft is transplanted from a genetically non-identical individual, the recipient’s immune system recognizes the graft as foreign.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-transplantation-therapeutics-a-highly-innovative-pipeline-with-a-range-of-adaptive-and-innate-immune-targeting-programs-focusing-on-graft-versus-host-disease-and-kidney-transplantation
Reasons To Buy
• Appreciate the current clinical and commercial landscapes by considering disease symptoms, pathogenesis, etiology, co-morbidities and complications, epidemiology, diagnosis, prognosis and treatment options for transplantation rejection.
• Identify leading products and key unmet needs within the market.
• Recognize trends in pipeline innovation by analyzing therapies by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary molecular target matrix assessment, first-in-class targets in the pipeline have been assessed and ranked according to clinical potential.
• Consider first-in-class pipeline products with no prior involvement in licensing and co-development deals, which may represent potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/935560
Scope
• There is a need for therapies that can achieve graft-specific immunosuppression, without having a general effect on the wider immune system. Which therapies and technologies currently in development are most likely to achieve this?
• There are 63 distinct first-in-class molecular targets in development for transplantation. Which of these hold the strongest potential in the clinic, and which are closest to reaching the market?
• How effective are current therapies for these indications, and how have they been able to improve the general prognosis in recent decades?
• Which molecule types and molecular targets are most prominent across transplantation therapy?
• Which specific types of transplantation are being most heavily studied across the pharmaceutical pipeline?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935560

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/transplantation-therapeutics-research-talks-about-leading-products-and-key-unmet-needs-within-the-market/314334

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-transplantation-therapeutics-a-highly-innovative-pipeline-with-a-range-of-adaptive-and-innate-immune-targeting-programs-focusing-on-graft-versus-host-disease-and-kidney-transplantation%20%20

Source: MarketersMedia

Release ID: 314334

More News From Daily Xtreme

Kerevi back for Wallabies, 3 uncapped players also in squad

Oct 19, 2018

SYDNEY — Center Samu Kerevi has been recalled and three uncapped players have been included in Australia's 31-man squad for the third Bledisloe Cup test against New Zealand in Japan on Oct. 27. Wallabies coach Michael Cheika announced the squad on Thursday, giving Waratahs forward Jed Holloway, scrumhalf Jake Gordon and Melbourne Rebels blindside flanker Angus Cottrell a chance to push for test selection. Kerevi, who missed the Rugby Championship with a biceps injury, hasn't played since the third test against Ireland in June. Reece Hodge, who started in the centers for the Wallabies in all six tests in Kerevi's...

New Zealand All Blacks select 51 for season-ending tour

Oct 19, 2018

WELLINGTON, New Zealand — The All Blacks have taken the unprecedented step of selecting a player based in Japan among an enlarged squad of 51 for autumn test matches against Australia, Japan, England, Ireland and Italy. Flanker Matt Todd, who is playing for the Panasonic Wild Knights in Japan's top domestic competition, has been picked for the European section of New Zealand's tour in the absence of Sam Cane, who is convalescing after fracturing his neck. Todd is set to return to New Zealand next year in time to play for the Christchurch-based Crusaders in Super Rugby but would normally...

Australian Grand Prix to lead off F1 2019 schedule

Oct 19, 2018

MELBOURNE, Australia — The Australian Grand Prix has taken its usual place at the top of the calendar for the 2019 Formula One season, with Melbourne to host the opening race on March 17 at Albert Park. World governing body FIA said following a meeting of its World Motor Sport Council on Friday that 21 races will be held next year, with 11 in Europe, five in Asia, four in the Americas and one in Australia. ___ Dates, races and venues for 2019: March 17: Australia, Melbourne March 31: Bahrain, Sakhir April 14: China, Shanghai April 28: Azerbaijan, Baku May...

East to west, Rugby Australia switches venue for Bledisloe

Oct 19, 2018

PERTH, Australia — Rugby Australia is moving one of the Bledisloe Cup tests west to Perth next year, hoping that a change from the traditional venues will bring about a change in the Wallabies' fortunes against a dominant New Zealand in the annual series. The All Blacks have held the Bledisloe Cup since 2003 and clinched this year's series with wins in the first two matches in Sydney and Auckland. A third match is to be played on neutral ground in Yokohama, Japan, on Oct. 27. Rugby Australia on Thursday said the Western Australia match would be held on Aug....

All Blacks experiment against Argentina ahead of World Cup

Oct 19, 2018

WELLINGTON, New Zealand — All Blacks coach Steve Hansen says Saturday's Rugby Championship test against Argentina in Buenos Aires is part of a two-match experiment, imperative to New Zealand's defense of the World Cup in Japan next year. Hansen said the All Blacks' last two matches against Argentina and South Africa will allow coaches and players to simulate conditions New Zealand might encounter in the knockout stages of a World Cup. He said if New Zealand reaches the playoff stages of the world tournament it will have to win two "big" matches to reach the final. Its next two tests...

NHL Livescore